AstraZeneca (AZN) PT Raised to $42 at Bernstein; 'Catalyst-Rich Year'
Tweet Send to a Friend
Bernstein raised its price target on AstraZeneca ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
